These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34449650)

  • 41. Are Posterior Oropharyngeal Saliva Specimens an Acceptable Alternative to Nasopharyngeal Sampling for the Monitoring of SARS-CoV-2 in Primary-Care Settings?
    Masse S; Bonnet C; Vilcu AM; Benamar H; Swital M; van der Werf S; Carrat F; Hanslik T; Blanchon T; Falchi A
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33926069
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of Specimen Types and Saliva Stabilization Solutions for SARS-CoV-2 Testing.
    Griesemer SB; Van Slyke G; Ehrbar D; Strle K; Yildirim T; Centurioni DA; Walsh AC; Chang AK; Waxman MJ; St George K
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33674284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Self-Collected Anterior Nasal and Saliva Specimens versus Health Care Worker-Collected Nasopharyngeal Swabs for the Molecular Detection of SARS-CoV-2.
    Hanson KE; Barker AP; Hillyard DR; Gilmore N; Barrett JW; Orlandi RR; Shakir SM
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32817233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of Patient Characteristics on Diagnostic Performance of Self-Collected Samples for SARS-CoV-2 Testing.
    Smith-Jeffcoat SE; Koh M; Hoffman A; Rebolledo PA; Schechter MC; Miller HK; Sleweon S; Rossetti R; Kasinathan V; Shragai T; O'Laughlin K; Espinosa CC; Khalil GM; Adeyemo AO; Moorman A; Bauman BL; Joseph K; O'Hegarty M; Kamal N; Atallah H; Moore BL; Bohannon CD; Bankamp B; Hartloge C; Bowen MD; Paulick A; Gargis AS; Elkins C; Stewart RJ; da Silva J; Biedron C; Tate JE; Wang YF; Kirking HL;
    Emerg Infect Dis; 2021; 27(8):2081-2089. PubMed ID: 34286681
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Viral Load Kinetics of SARS-CoV-2 Infection in Saliva in Korean Patients: a Prospective Multi-center Comparative Study.
    Kim SE; Lee JY; Lee A; Kim S; Park KH; Jung SI; Kang SJ; Oh TH; Kim UJ; Lee SY; Kee SJ; Jang HC
    J Korean Med Sci; 2020 Aug; 35(31):e287. PubMed ID: 32776725
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Self-Collected Saline Gargle Samples as an Alternative to Health Care Worker-Collected Nasopharyngeal Swabs for COVID-19 Diagnosis in Outpatients.
    Goldfarb DM; Tilley P; Al-Rawahi GN; Srigley JA; Ford G; Pedersen H; Pabbi A; Hannam-Clark S; Charles M; Dittrick M; Gadkar VJ; Pernica JM; Hoang LMN
    J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33514627
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of Lumipulse® G SARS-CoV-2 antigen assay automated test for detecting SARS-CoV-2 nucleocapsid protein (NP) in nasopharyngeal swabs for community and population screening.
    Gili A; Paggi R; Russo C; Cenci E; Pietrella D; Graziani A; Stracci F; Mencacci A
    Int J Infect Dis; 2021 Apr; 105():391-396. PubMed ID: 33647511
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Rapid, High-Sensitivity SARS-CoV-2 Nucleocapsid Immunoassay to Aid Diagnosis of Acute COVID-19 at the Point of Care: A Clinical Performance Study.
    Drain PK; Ampajwala M; Chappel C; Gvozden AB; Hoppers M; Wang M; Rosen R; Young S; Zissman E; Montano M
    Infect Dis Ther; 2021 Jun; 10(2):753-761. PubMed ID: 33629225
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Equivalent SARS-CoV-2 viral loads by PCR between nasopharyngeal swab and saliva in symptomatic patients.
    Yokota I; Hattori T; Shane PY; Konno S; Nagasaka A; Takeyabu K; Fujisawa S; Nishida M; Teshima T
    Sci Rep; 2021 Feb; 11(1):4500. PubMed ID: 33627730
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical Validation of a Sensitive Test for Saliva Collected in Healthcare and Community Settings with Pooling Utility for Severe Acute Respiratory Syndrome Coronavirus 2 Mass Surveillance.
    Sahajpal NS; Mondal AK; Ananth S; Njau A; Ahluwalia P; Kota V; Caspary K; Ross TM; Farrell M; Shannon MP; Fulzele S; Chaubey A; Hegde M; Rojiani AM; Kolhe R
    J Mol Diagn; 2021 Jul; 23(7):788-795. PubMed ID: 33957320
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples.
    Porte L; Legarraga P; Vollrath V; Aguilera X; Munita JM; Araos R; Pizarro G; Vial P; Iruretagoyena M; Dittrich S; Weitzel T
    Int J Infect Dis; 2020 Oct; 99():328-333. PubMed ID: 32497809
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Time-course evaluation of the quantitative antigen test for severe acute respiratory syndrome coronavirus 2: The potential contribution to alleviating isolation of COVID-19 patients.
    Nomoto H; Yamamoto K; Yamada G; Suzuki M; Kinoshita N; Takasaki J; Moriya A; Maeda K; Kimura M; Ohmagari N
    J Infect Chemother; 2021 Nov; 27(11):1669-1673. PubMed ID: 34454833
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Durability of Spike Immunoglobin G Antibodies to SARS-CoV-2 Among Health Care Workers With Prior Infection.
    Egbert ER; Xiao S; Colantuoni E; Caturegli P; Gadala A; Milstone AM; Debes AK
    JAMA Netw Open; 2021 Aug; 4(8):e2123256. PubMed ID: 34459910
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273.
    Steensels D; Pierlet N; Penders J; Mesotten D; Heylen L
    JAMA; 2021 Oct; 326(15):1533-1535. PubMed ID: 34459863
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vaccine against SARS-CoV-2 in previously infected health care workers.
    Parisi SG
    EBioMedicine; 2021 Sep; 71():103556. PubMed ID: 34454402
    [No Abstract]   [Full Text] [Related]  

  • 56. Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid organ transplant recipients.
    Schmidt T; Klemis V; Schub D; Schneitler S; Reichert MC; Wilkens H; Sester U; Sester M; Mihm J
    Am J Transplant; 2021 Dec; 21(12):3990-4002. PubMed ID: 34453872
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neutralization of SARS-CoV-2 requires antibodies against conformational receptor-binding domain epitopes.
    Gattinger P; Niespodziana K; Stiasny K; Sahanic S; Tulaeva I; Borochova K; Dorofeeva Y; Schlederer T; Sonnweber T; Hofer G; Kiss R; Kratzer B; Trapin D; Tauber PA; Rottal A; Körmöczi U; Feichter M; Weber M; Focke-Tejkl M; Löffler-Ragg J; Mühl B; Kropfmüller A; Keller W; Stolz F; Henning R; Tancevski I; Puchhammer-Stöckl E; Pickl WF; Valenta R
    Allergy; 2022 Jan; 77(1):230-242. PubMed ID: 34453317
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine Among Actively Treated Cancer Patients.
    Ligumsky H; Safadi E; Etan T; Vaknin N; Waller M; Croll A; Nikolaevski-Berlin A; Greenberg I; Halperin T; Wasserman A; Galazan L; Arber N; Wolf I
    J Natl Cancer Inst; 2022 Feb; 114(2):203-209. PubMed ID: 34453830
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A COVID-19 Epidemic Model Predicting the Effectiveness of Vaccination in the US.
    Webb G
    Infect Dis Rep; 2021 Jul; 13(3):654-667. PubMed ID: 34449651
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Psychological Effects of Screen Time in Health Care Workers During the COVID-19 Pandemic.
    Le C; Khalid Z; Avramut C; Lam A; Ragina N; Zyzanski S
    Prim Care Companion CNS Disord; 2021 Aug; 23(5):. PubMed ID: 34449985
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.